Categories: News

CELLTREAT Teams Up With Bioz to Enhance Research Capabilities With Scientific Citations

PALO ALTO, CA / ACCESSWIRE / April 17, 2024 / Bioz, Inc., a leading AI software company committed to scientific discovery, is excited to announce its strategic partnership with CELLTREAT, a prominent player in the realm of laboratory consumables.

Bioz Original Badge
Bioz Original Badge on CELLTREAT’s Website

In this exciting partnership, Bioz has integrated its innovative digital tools, called Bioz Badges, directly onto CELLTREAT’s product webpages. These widgets deliver real-time citation data to the webpage, empowering researchers in their decision-making processes. Offering snippets from peer-reviewed scientific publications, live citation counts, and objective Bioz Stars ratings, these tools provide invaluable validation for CELLTREAT’s clientele, ultimately enhancing the efficacy of their research initiatives.

“We’ve observed a significant rise in user engagement as we showcase how our products have contributed to previous research endeavors,” remarks Tyler Chapman, Director of Sales at CELLTREAT, further adding that “this enhancement not only benefits researchers but also serves as a valuable internal resource.”

Dr. Karin Lachmi, Co-founder and CRO of Bioz, shares her enthusiasm for this collaboration, stating, “We are thrilled to celebrate a partnership with CELLTREAT and are honored to align ourselves with a company dedicated to providing such high-quality consumables in this industry.”

CELLTREAT offers an impressive array of consumables within the liquid handling and cell culture space such as pipets, tubes, flasks, etc. These product contributions to the research space are reinforced by peer-reviewed publications, highlighted through Bioz Badges. Integrations of these Badges effectively demonstrate product utility in peer-reviewed literature, poised to empower researchers with confidence while enforcing the joint commitment of both companies to propel scientific exploration forward.

About Bioz

Bioz is the world’s most advanced AI search engine for life science experimentation, with evidence-based product ratings and recommendations to guide biopharma and academic scientists toward the most validated products to use in their experiments, which accelerates research toward new discoveries. Bioz’s solutions for suppliers include Bioz Badges and Content Hubs, web-based widgets, that are placed on product supplier websites to increase user engagement and sales conversion.

Helpful Links

To learn more about Bioz solutions for suppliers, please reach out to info@bioz.com.

Contact Information

Daniel Levitt
CEO
pr@bioz.com

Tyler Chapman
Director of Sales
tylerc@celltreat.com

SOURCE: Bioz, Inc.

View the original press release on newswire.com.

Staff

Recent Posts

Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a…

16 mins ago

$1.25 Billion Parenteral Nutrition Bags Markets by Chamber Type, Consumer, End User – Global Forecast to 2031 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Parenteral Nutrition Bags Market by Chamber Type (Single-Chamber Bags, Dual-Chamber Bags, Multi-Chambered Bags),…

17 mins ago

Three Finalists Announced for the 2024 Bloom Burton Award

Recognizing the Year's Most Significant Contributions to Canada's Innovative Healthcare IndustryToronto, Ontario--(Newsfile Corp. - April…

18 mins ago

TrackFive’s TravelNurseSource Revolutionizes Healthcare Recruiting With the Launch of QuickConnect

TravelNurseSource is set to enhance candidate matching and reduce client costs, delivering superior outcomes compared…

18 mins ago

Stemtech Corporation on Track for CEO and Chairman’s Goal for Growth and Global Expansion

Industry Recognition: Stemtech Ranked Top 5% in Direct Selling by 'Business for Home'"NAPLES, FL /…

18 mins ago

Sunshine Biopharma’s Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

NEW YORK, NY / ACCESSWIRE / April 19, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a…

18 mins ago